Gagandeep Kaur

About

Gagandeep Kaur is a biomaterial researcher and educator who has expertise in working on interdisciplinary fields especially on the edge of chemistry and biology. She is passionate about engineering new biomaterials with the ability to change the course line for the healthcare and biomedical field. Strong leadership skills, work ethics and will power be strong points in her personality. She is a good communicator, friendly and great team player for any interdisciplinary research institute.

www.gagandeepkalsi.com
https://www.linkedin.com/in/gagandeep-kaur-ph-d-14391a70/

Employment

• Howard University Assistant Professor
  2022 - Present
• Texas A&M University Postdoctoral Research Associate
  2019 - 2022
• Texas A&M University Postdoctoral Research Associate
  2017 - 2019
• Indian Institute of Technology Kanpur Project Scientist
  2017 - 2017

Education

• Indian Institute of Technology Kanpur PhD
  2011 - 2017

Projects & Funding

Projects & funding information is unavailable.

Publications (23)

• Advanced silicone materials for soft actuator applications
  RSC Applied Polymers 2026 DOI: 10.1039/D5LP00290G
  +Save
• Ethoxy Acetalated Dextran-Based Biomaterials for Therapeutic Applications
  Polymers 2024 DOI: 10.3390/polym16192756
  +Save
• Biopotency and surrogate assays to validate the immunomodulatory potency of extracellular vesicles derived from mesenchymal stem/stromal cells for the treatment of experimental autoimmune uveitis
  J. Extracell Vesicles. 2024
  +Save
• ELECTROSPUN FIBROUS NANOMAT COMPOSITION AND A METHOD OF SYNTHESIZING THE SAME FOR CANCER CELL DETECTION
  2023
  +Save
• Kinetic versus thermodynamic polymorph stabilization of a tri-carboxylic acid derivative at the solid–liquid interface
  Nanoscale 2023 DOI: 10.1039/D3NR02031B
  +Save
• MHC Class I Enables MSCs to Evade NK-Cell–Mediated Cytotoxicity and Exert Immunosuppressive Activity
  Stem Cells 2022 DOI: 10.1093/stmcls/sxac043
  +Save
• A scalable system for generation of mesenchymal stem cells derived from induced pluripotent cells employing bioreactors and degradable microcarriers
  STEM CELLS Translational Medicine 2021 DOI: 10.1002/sctm.21-0151
  +Save
• Small Molecule Inhibitors for Amyloid Aggregation
  Biological Soft Matter 2021 DOI: 10.1002/9783527811014.ch6
  +Save
• Identification of Molecules Responsible for Therapeutic Effects of Extracellular Vesicles Produced from iPSC-Derived MSCs on Sjo¨gren’s Syndrome
  Aging and disease 2021 DOI: 10.14336/ad.2021.0621
  +Save
• Spin coating mediated morphology modulation in self assembly of peptides
  Nanoscale 2021 DOI: 10.1039/d0nr09082d
  +Save